Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism
Date of publication: 06-02-2018
FDA has received seven reports of patients experiencing PE during, or soon after, a treatment. Źródło: https://www.fda.gov
